Literature DB >> 9284525

Interactions of the human papillomavirus E7 protein with cell cycle regulators.

D L Jones1, K Münger.   

Abstract

Human papillomavirus (HPVs) critically depend on the cellular machinery for the replication of their genome. Viral replication is restricted to the differentiated strata of the skin that are normally growth arrested. Hence, the HPVs have developed strategies to subvert cellular growth regulatory pathways and are able to uncouple cellular proliferation and differentiation. The HPV E7 protein can overcome the activity of some cyclin-dependent kinase inhibitors, associate with cyclin/cyclin dependent kinase complexes and bind to and destabilize the retinoblastoma tumor suppressor protein. These biological activities contribute to the carcinogenic potential of the high risk HPV E7 proteins which are consistently expressed in HPV-positive cervical carcinomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9284525     DOI: 10.1006/scbi.1996.0042

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  28 in total

1.  Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.

Authors:  M Nees; J M Geoghegan; T Hyman; S Frank; L Miller; C D Woodworth
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.

Authors:  S T Oh; S Kyo; L A Laimins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity.

Authors:  J K Choi; S Ishido; J U Jung
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

6.  Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.

Authors:  D A Francis; S I Schmid; P M Howley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Nuclear import of cutaneous beta genus HPV8 E7 oncoprotein is mediated by hydrophobic interactions between its zinc-binding domain and FG nucleoporins.

Authors:  Zeynep Onder; Junona Moroianu
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

8.  Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins.

Authors:  Marta Melar-New; Laimonis A Laimins
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

9.  Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes.

Authors:  J T Thomas; S T Oh; S S Terhune; L A Laimins
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

10.  Identification of the nuclear localization and export signals of high risk HPV16 E7 oncoprotein.

Authors:  Alixandra A Knapp; Patrick M McManus; Katy Bockstall; Junona Moroianu
Journal:  Virology       Date:  2008-11-08       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.